CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from β-chemokines

Viral Immunology

Volumn 13, Issue 4, 2000, Pages 481-495

  Mosoian, A ^a   Teixeira, A ^a   Caron, E ^a   Piwoz, J ^a   Klotman, M E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA CHEMOKINE; BETA INTERFERON; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CHILD; CONTROLLED STUDY; CYTOLYSIS; DISEASE COURSE; FRACTIONATION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ION EXCHANGE CHROMATOGRAPHY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PH; PHENOTYPE; SUPERNATANT; THERMOSTABILITY; VIRUS ACTIVATION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0034505915     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2000.13.481     Document Type: Article

References (55)

1. Features of children perinatally infected with HIV-1 surviving longer than 5 years
2. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants
3. HIV suppression by interleukin-16
4. + cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines
5. + T cell suppressor activities: Dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation
6. Stable growth transformation of human T lymphocytes by herpesvirus saimiri
7. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
8. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: A novel antiviral mechanism
9. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
10. + T cell supernatants of HIV type 1-infected individuals have opposite effects on long terminal repeat-mediated transcription in T cells and monocytes
11. + T cells is not lentivirus specific
12. + T cells is dependent on the NFAT-1 element
13. Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine
14. Identification of a major co-receptor for primary isolates of HIV-1
15. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: Importance of viral RNA and the timing of transmission on long-term outcome
16. + cells is mediated by the chemokine receptor CC- CKR-5
17. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
18. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: Implications for latency
19. Enhancement of human immunodeficiency virus type 1 infection by the CC- chemokine RANTES is independent of the mechanism of virus-cell fusion
20. Noncytolytic CD8 T cell-mediated suppression of HIV replication
21. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4
22. ++ population
23. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: Role of signal transduction
24. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
25. + T cell suppression of syncytia-inducing strains of HIV-1
26. + lymphocytes from an HIV type 1-infected asymptomatic individual
27. + T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta
28. CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children
29. + T cells
30. + cell anti-HIV activity: Nonlytic suppression of virus replication
31. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription
32. + T cell lines with noncytotoxic anti-HIV activity
33. + cell anti-HIV activity correlates with the clinical state of the infected individual
34. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection
35. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
36. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
37. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages
38. + cells are distinct from RANTES, MIP-1a and MIP-1b
39. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
40. Herpesvirus saimiri transformed human T cell lines: A permissive system for human immunodeficiency viruses
41. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1
42. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro
43. Inhibition of HIV-1 infection by the beta-chemokine MDC
44. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
45. Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation
46. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines
47. + T-cell-mediated suppression of HIV replication in the first year of life: Association with lower viral load and favorable early survival
48. + T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells
49. + T cell-mediated suppression of HIV replication: Beta-chemokine-dependent and -independent effects
50. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response
51. Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor
52. + cells involves a noncytotoxic mechanism
53. + T lymphocytes suppresses HIV replication
54. Transformation of human T-cell clones by Herpesvirus saimiri: Intact antigen recognition by autonomously growing myelin basic protein-specific T cells
55. + cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms